Why David Einhorn’s Greenlight prefers this tiny biotech over AI
‘excitement’
-
Greenlight Capital’s third-quarter investor letter had almost nothing good
to say about the hot AI trend, but it does have faith in a tiny biotech.
35 minutes ago
No comments:
Post a Comment
social network